VRDN Executive Compensation

* In USD (Original Currency)
Filing Date
(SEC Report)
Year Reporting Name Salary Bonus Stock Award Incentive Plan Compensation Other Compensation Total
2023-04-28 2022 Jonathan Violin, Ph.D. Former President, Chief Executive Officer and Director 601,200 288,576 0 0 2,320 4,646,740
2023-04-28 2021 Barrett Katz, M.D. Chief Medical Officer 440,833 404,800 0 0 13,338 8,167,089
2023-04-28 2022 Barrett Katz, M.D. Chief Medical Officer 487,600 136,528 0 0 11,488 2,110,655
2023-04-28 2021 Kristian Humer Chief Financial and Business Officer 230,871 686,200 0 0 1,100 7,708,958
2023-04-28 2022 Kristian Humer Chief Financial and Business Officer 561,800 252,810 0 0 2,320 2,023,780
2023-04-28 2021 Jonathan Violin, Ph.D. Former President, Chief Executive Officer and Director 567,000 408,240 0 0 9,021 17,408,538
2022-04-27 2020 Lee Rauch Former President and Chief Executive Officer and Director 256,436 270,500 0 0 3,798 1,670,411
2022-04-27 2021 Barrett Katz 440,833 404,800 0 0 13,338 8,167,089
2022-04-27 2021 Jonathan Violin, Ph.D. President, Chief Executive Officer and Director 567,000 408,240 0 0 9,021 17,408,538
2022-04-27 2021 Lee Rauch Former President and Chief Executive Officer and Director 22,542 541,000 0 0 907,557 1,779,054
2022-04-27 2021 Kristian Humer Chief Financial and Business Officer 230,871 686,200 0 0 1,100 7,708,958
2021-04-30 2020 Diana Escolar, M.D. Former Chief Medical Officer 417,473 277,780 0 0 5,873 865,618
2021-04-30 2020 William S. Marshall, Ph.D. Former President and Chief Executive Officer 424,832 0 0 0 1,176,859 2,186,819
2021-04-30 2019 William S. Marshall, Ph.D. Former President and Chief Executive Officer 521,000 0 0 0 3,640 1,075,942
2021-04-30 2020 Lee Rauch Former President, Chief Executive Officer and Director 256,436 270,500 0 0 3,798 1,670,411
2021-04-30 2020 Jason A. Leverone Chief Financial Officer, Treasurer, and Secretary 365,650 0 0 0 4,655 483,020
2021-04-30 2019 Jason A. Leverone Chief Financial Officer, Treasurer, and Secretary 355,000 0 0 0 4,584 537,807
2021-04-30 2019 Diana Escolar, M.D. Former Chief Medical Officer 372,600 111,780 0 0 6,217 550,005
2020-04-10 2019 Paul D. Rubin, M.D. Former Executive Vice President, Research and Development 426,000 0 0 0 0 632,738
2020-04-10 2018 Paul D. Rubin, M.D. Former Executive Vice President, Research and Development 410,000 0 0 98,400 0 976,769
2020-04-10 2019 William S. Marshall, Ph.D. President and Chief Executive Officer 521,000 0 0 0 0 1,072,302
2020-04-10 2018 William S. Marshall, Ph.D. President and Chief Executive Officer 490,000 0 0 147,000 0 1,987,005
2020-04-10 2019 Jason A. Leverone Chief Financial Officer 355,000 0 0 0 0 533,223
2020-04-10 2018 Jason A. Leverone Chief Financial Officer 340,000 0 0 71,400 0 824,667
2020-04-10 2019 Diana Escolar, M.D. Chief Medical Officer 372,600 111,780 0 0 0 543,788
2020-04-10 2018 Diana Escolar, M.D. Chief Medical Officer 0 0 0 0 0 0
2017-05-15 2016 Tamara A. Seymour Chief Financial Officer 350,000 105,000 51,000 0 0 506,000
2017-05-15 2015 Samuel D. Riccitelli Chief Executive Officer and President 450,000 135,000 0 0 0 585,000
2017-05-15 2015 Tamara A. Seymour Chief Financial Officer 350,000 105,000 0 0 0 508,070
2017-05-15 2016 Samuel D. Riccitelli Chief Executive Officer and President 450,000 135,000 102,000 0 0 687,000
2016-05-09 2014 Samuel D. Riccitelli Chief Executive Officer 450,000 90,000 7,455,110 0 24,164 8,019,274
2016-05-09 2014 Tamara A. Seymour Chief Financial Officer 144,712 43,414 468,280 0 1,398 657,804
2016-05-09 2015 Tamara A. Seymour Chief Financial Officer 350,000 26,250 0 0 0 429,320
2016-05-09 2015 Samuel D. Riccitelli Chief Executive Officer 450,000 33,750 0 0 0 483,750
2015-05-26 2013 Samuel D. Riccitelli Chief Executive Officer 450,000 0 0 0 114,947 564,947
2015-05-26 2014 Samuel D. Riccitelli Chief Executive Officer 450,000 90,000 7,455,110 0 24,164 8,019,274
2015-05-26 2014 Tamara A. Seymour 144,712 43,414 468,280 0 1,398 657,804

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.